Sugar, E. A., Holbrook, J. T., Kempen, J. H., Burke, A. E., Drye, L. T., Thorne, J. E., … Frick, K. D. (2014). Cost-Effectiveness of Fluocinolone Acetonide Implant versus Systemic Therapy for Noninfectious Intermediate, Posterior, and Panuveitis. Ophthalmology, 121(10), 1855–1862. https://doi.org/10.1016/j.ophtha.2014.04.022

Sugar, Elizabeth A., Janet T. Holbrook, John H. Kempen, Alyce E. Burke, Lea T. Drye, Jennifer E. Thorne, Thomas A. Louis, Douglas A. Jabs, Michael M. Altaweel, and Kevin D. Frick. “Cost-Effectiveness of Fluocinolone Acetonide Implant versus Systemic Therapy for Noninfectious Intermediate, Posterior, and Panuveitis.” Ophthalmology 121, no. 10 (October 2014): 1855–62. https://doi.org/10.1016/j.ophtha.2014.04.022.

Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, et al. Cost-Effectiveness of Fluocinolone Acetonide Implant versus Systemic Therapy for Noninfectious Intermediate, Posterior, and Panuveitis. Ophthalmology. 2014 Oct;121(10):1855–62.

Sugar, Elizabeth A., et al. “Cost-Effectiveness of Fluocinolone Acetonide Implant versus Systemic Therapy for Noninfectious Intermediate, Posterior, and Panuveitis.” Ophthalmology, vol. 121, no. 10, Elsevier BV, Oct. 2014, pp. 1855–62. Crossref, doi:10.1016/j.ophtha.2014.04.022.

Sugar EA, Holbrook JT, Kempen JH, Burke AE, Drye LT, Thorne JE, Louis TA, Jabs DA, Altaweel MM, Frick KD. Cost-Effectiveness of Fluocinolone Acetonide Implant versus Systemic Therapy for Noninfectious Intermediate, Posterior, and Panuveitis. Ophthalmology. Elsevier BV; 2014 Oct;121(10):1855–1862.